Full name
BIOVETA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
73.20.Z - Market research and public opinion polling
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.46.Z - Wholesale of pharmaceutical goods
52.10.B - Warehousing and storage of other goods
58.14.Z - Publishing of journals and periodicals
63.99.Z - Other information service activities not elsewhere classified
85.60.Z - Educational support activities
96.09.Z - Other personal service activities not elsewhere classified
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Net sales | 1,1 | 1,2 | 1,2 | 2,3 |
Liabilities and provisions | 0,2 | 0,2 | 0,3 | 35 |
Equity | 0,2 | 0,1 | 0 | -60 |
Total assets | 0,4 | 0,3 | 0,3 | 2,8 |
Cash and cash equivalents | 0,1 | 0,1 | 0,1 | 62,5 |
Depreciation | 0 | 0 | 0 | -30,6 |
Gross profit / loss | 0,1 | -0,1 | -0,1 | 6,8 |
EBITDA | 0,1 | 0 | 0 | -30,2 |
Current assets | 0,3 | 0,2 | 0,3 | 15,2 |
Operating profit (EBIT) | 0,1 | -0 | -0 | 30,7 |
Net profit / loss | 0,1 | -0,1 | -0,1 | 6,8 |
% | % | % | p.p. | |
Return on equity (ROE) | 46,7 | -64,4 | -150,2 | -85,8 |
Return on sales (ROS) | 7,4 | -5,7 | -5,2 | 0,5 |
Equity ratio | 43,8 | 33,9 | 13,2 | -20,7 |
EBITDA margin | 12,9 | 0,3 | 0,2 | -0,1 |
Gross profit margin | 7,4 | -5,7 | -5,2 | 0,5 |
Days | Days | Days | Days | |
Current liabilities turnover ratio | 21 | 29 | 27 | -2 |